ReviewCurrent treatment options in oncology2005
Diagnosis and management of synovial sarcoma.
Review in Current treatment options in oncology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 37 citations in OpenAlex.
- A Rare Case of Primary Laryngeal Synovial Sarcoma, Challenges in Diagnosis and Management in a Resource-Limited Setup: A Case Report.Case reports in otolaryngology · 2025Article
- Synovial Sarcoma of the Larynx: Report of a Case and Review of Literature.Case reports in otolaryngology · 2017Article
- Synovial sarcoma of the spine: a case involving paraspinal muscle with extensive calcification and the surgical consideration in treatment.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2014Review
- Primary giant mediastinal synovial sarcoma of the neck: A case report and review of the literature.Oncology letters · 2014Article
- Giant subcutaneous synovial sarcoma: an interesting case.Journal of clinical and diagnostic research : JCDR · 2013Article
- Laryngeal synovial sarcoma: a rare clinical entity.Case reports in otolaryngology · 2013Article
- Primary synovial sarcoma of the parapharyngeal space: a clinicopathologic study of five cases.World journal of surgical oncology · 2012Article
- Synovial sarcoma of the spine: A report of three cases and review of the literature.Surgical neurology international · 2011Article
- Metastatic poorly differentiated monophasic synovial sarcoma to lung with unknown primary: a molecular genetic analysis.International journal of clinical and experimental pathology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synovial sarcoma is a unique tumor with substantial promise for biologically targeted therapy. Although it demonstrates moderate chemosensitivity, with approximately 50% response rates to ifosfamide- and doxorubicin-containing regimens, it has a diagnostic translocation and a potentially informative chimeric protein product. Although surgical management remains the cornerstone to effect local control, therapeutic advancements are unlikely to occur by continuing to include advanced cases of synovial sarcomas in trials with other soft tissue sarcomas. Rather, attention should be turned toward prospective molecular targets and development of novel agents to exploit them. Research should be directed at understanding the fusion protein of the X,18 translocation and further validating the role of overexpressed proteins in synovial sarcoma. Meanwhile, carefully designed clinical trials of these agents, with translational correlates, will provide in vivo data to complement the preclinical experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.